Participants who took tirzepatide — which is sold as Zepbound by Eli Lilly — lost an average of 50 pounds over 72 weeks.

Houston-based Empower Pharmacy has repeatedly been admonished by the FDA for failing to follow federal rules that ensure drug ...

The first head-to-head trial of Mounjaro and Wegovy, the weight-loss drugs, compared the effectiveness of the two leading ...

Global pharmaceutical stocks fell on Monday after President Donald Trump vowed to cut U.S. prescription drug prices to match ...

Empower Pharmacy, a Houston-based compounding pharmacy, has attracted media attention over the last decade for its rapid expansion in the region, with the company opening two large facilities that ...

New data shows Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy in weight loss, with 65% vs 40% of patients achieving ...